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882Objective: Our objective was to assess the relationships of a hospital’s past adjusted in-hospital mortality and
surgical volume with future in-hospital mortality after surgery for congenital heart disease.
Methods: Using the Pediatric Health Information Systems database, we (1) calculated hospital surgical volume
and standardized mortality ratio (¼ observed number of deaths/expected number of deaths adjusted for surgery
type) for January 2004 through June 2006 for children (0-18 years) after surgery for congenital heart disease at
38 hospitals and (2) assessed the relationship between these values and subsequent mortality during July 2006
through December 2008. We constructed Poisson regression models to estimate risk of mortality, adjusting for
age, race, sex, genetic syndrome, insurance type, and surgery type (using the Risk Adjustment in Congenital
Heart Surgery method).
Results: There were 49,792 hospital encounters during 2004 through 2008 for pediatric patients having surgery
for congenital heart disease, with an overall in-hospital mortality of 3.45%. For the 24,112 eligible encounters
during July 2006 through December 2008, a hospital’s prior standardized mortality ratio was significantly asso-
ciated with postoperative in-hospital mortality (P<.0001), and a hospital’s prior surgical volume had only bor-
derline significance (P ¼ .0792). On stratified analysis, past standardized mortality ratio was associated with
mortality for both lower- and higher-risk surgical risk categories (P ¼ .0105 and .0015, respectively). Hospital
surgical volume was not significantly associated with mortality for lower-risk categories (P¼ .4122), but it was
borderline significant for higher-risk categories (P ¼ .0678).
Conclusions: In this data set, prior hospital surgical volume tended to be associated with improved mortality
after higher-risk operations in pediatric patients with congenital heart disease, whereas prior hospital postoper-
ative mortality was significantly associated with mortality across all risk strata of congenital heart surgery.
(J Thorac Cardiovasc Surg 2011;142:882-6)In the current health care environment, greater emphasis is
now being placed on outcomes and quality.1 One key out-
come that has been identified as a marker of the quality of
a hospital is surgical mortality.2,3 Greater hospital surgical
volume has been shown to be associated with lower in-
hospital mortality for a variety of operations in adults.4 Sim-
ilarly, many researchers have identified surgical volume as
a significant predictor of in-hospital mortality after surgery
for congenital heart disease.5-12 As such, some insurance
companies are using hospital surgical case volume as part
of a basis for determination of and referral to centers of
excellence in surgery for congenital heart disease.13
However, these efforts have largely ignored the effect that
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The Journal of Thoracic and Cardiovascular Surgcomes. In a study of low-birth-weight infants, past hospital
mortality was more important than past hospital volume in
predicting future outcomes.14 We sought to determine
whether a similar relationship is true for congenital heart
disease outcomes. We hypothesized that prior standardized
in-hospital mortality ratio (SMR) is a significant predictor
of future in-hospital mortality after surgery for congenital
heart disease even after accounting for hospital surgical
volume.
METHODS
Data Source
We used data from the Pediatric Health Information System (PHIS) da-
tabase, a large, multi-center administrative database.15 Data are collected
from pediatric tertiary care hospitals that are members of the Child Health
Corporation of America. This organization offers a range of products and
services to its member hospitals to reduce hospital costs, increase revenue,
strengthen the competitive position of the hospitals, and improve the qual-
ity of care for children. To assist with these quality improvement efforts,
member hospitals contribute data on demographics, diagnoses, procedures,
interventions, and outcomes for all inpatient encounters.
Patient Population
We included in our analyses all children (aged 0-18 years) who under-
went surgery for congenital heart disease from January 1, 2004, to Decem-
ber 31, 2008, at institutions that contributed to the PHIS database during the
entire study period and that had at least 50 eligible encounters in the firstery c October 2011
Abbreviations and Acronyms
ICD-9 ¼ International Classification of
Diseases, Ninth Revision
PHIS ¼ Pediatric Health Information System
RACHS-1 ¼ Risk Adjustment for Congenital
Heart Surgery (method)
SMR ¼ standardized in-hospital mortality
ratio
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Dhalf of the study period. For each hospital encounter, we used International
Classification of Diseases, Ninth Revision (ICD-9), codes to determine the
highest risk category for that encounter using the Risk Adjustment for Con-
genital Heart Surgery method (RACHS-1).16 We excluded from our anal-
yses encounters in which a RACHS-1 category could not be assigned.
Study Variables
Patient variables that were collected included age, race (white, black,
other), sex, presence of genetic syndrome (yes/no), insurance type (govern-
ment, private, other), surgery risk category (using the RACHS-1 method),
and discharge status (death vs other). Using the information from the
PHIS database, we calculated hospital surgical volume and SMR
(SMR ¼ observed number of deaths/expected number of deaths adjusted
for surgery type) for January 2004 through June 2006 and July 2006
through December 2008 separately. To calculate a risk-adjusted SMR for
each hospital, we first determined the overall mortality for each RACHS-
1 category across all hospitals; we then used these mortality estimates to
calculate the expected number of deaths at each hospital given the number
of particular RACHS-1 category cases at that hospital.
Statistical Analysis
In the first part of our analysis, we assessed the correlation between an
institution’s prior SMR or surgical volume with its future SMR. To do
this, we calculated Spearman correlation coefficients among the hospital
surgical volumes and SMRs from January 2004 through June 2006 with
the hospital SMRs from July 2006 through December 2008. In the second
part of our analysis, we estimated the risk of in-hospital mortality for chil-
dren undergoing surgery for congenital heart disease during July 2006
through December 2008 by constructing generalized estimating equation
Poisson regression models. We considered the institutional-level variables
of hospital surgical volume and SMR from January 2004 through June
2006 as independent variableswhile adjusting for the patient-level variables
of age, race, sex, genetic syndrome, insurance type, and surgery risk cate-
gory (using the RACHS-1 method). Owing to small case counts for
RACHS-1 category 5, we combined this group with RACHS-1 category 6
in our regression model. To evaluate whether the effects of surgical volume
and SMR varied by surgical risk group, we performed stratified analysis by
lower-risk (RACHS-1categories 1, 2, and 3) andhigher-risk (RACHS-1 cat-
egories 4, 5, and 6) subtypes. For this analysis, we calculated and used the
specific risk-adjusted hospital SMRs and case loads for the lower-risk and
higher-risk categories. Because several children had more than 1 surgical
encounter, we used robust variance estimation in all of our regression
models to account for the lack of independence.17 From these models we
calculated adjusted risk ratios and 95% confidence intervals. All analyses
were performed using SAS version 9.2 (SAS Institute, Inc, Cary, NC).
RESULTS
For the period of January 1, 2004, through December 31,
2008, the PHIS database included49,792 hospital encountersThe Journal of Thoracic and Cafor congenital heart surgery at 39 children’s hospitals, with
an overall in-hospital mortality of 3.45%. During January
2004 through June 2006, hospital surgical volume ranged
from 9 to 1555 encounters (median 530), and SMR ranged
from 0.49 to 3.22 (median 0.99). After excluding the 1 hos-
pital with fewer than 50 encounters during the first half of
the study period, there were 24,112 eligible encounters at
38 children’s hospitals during July 2006 through December
2008, with an overall in-hospital mortality of 3.21%.
In univariate analysis, there was a positive relationship
between a hospital’s SMR from January 2004 through
June 2006 and the subsequent SMR from July 2006 through
December 2008 (P¼ .0002) (Figure 1). Similarly, there was
an inverse relationship between prior hospital surgical vol-
ume and subsequent SMR (P¼ .0089). However, the linear
relationship between prior SMR and subsequent SMR
(R2 ¼ 0.32) was notably higher than the linear relationship
between prior surgical volume and subsequent SMR
(R2 ¼ 0.18).
We then conducted further analysis to investigate the as-
sociations of prior hospital SMR and prior hospital surgical
volume with future patient mortality. Results from the gen-
eralized estimating equation Poisson regression models,
with hospital surgical volume and SMR from January
2004 through June 2006 as independent variables while ad-
justing for age, race, sex, genetic syndrome, insurance type,
and surgery type, are presented in Table 1. On average, for
every 0.1-unit decrease in prior hospital SMR, there was
a 3.4% decrease in the relative risk of inpatient mortality
(P<.0001). Prior hospital surgical volume was of border-
line significance (P ¼ .0792), with an increase in surgical
volume of 40 cases annually corresponding to a decrease
in relative risk of inpatient mortality of 2.0%.
In stratified analysis by RACHS-1 category, prior risk-
adjusted hospital SMRwas significantly associated with fu-
ture mortality for both lower-risk RACHS-1 categories
(P ¼ .0105) and higher-risk categories (P ¼ .0015). Prior
hospital surgical volume was not significant for lower-risk
categories (P ¼ .4122) but was of borderline significance
for higher-risk categories (P ¼ .0678) (Table 2).
DISCUSSION
In our study, prior hospital surgical volume was signifi-
cantly associated with decreased postoperative mortality,
a finding that is similar to the results of many prior stud-
ies.5-12 After adjusting for multiple factors including prior
hospital surgical mortality, prior surgical volume tended
toward significance for higher-risk operations for congeni-
tal heart disease but was not significant for lower-risk
operations for congenital heart disease. Prior in-hospital
mortality was significantly associated with future in-
hospital mortality after surgery for congenital heart disease
across all risk strata, even after adjusting for multiple fac-
tors including prior hospital surgical volume.rdiovascular Surgery c Volume 142, Number 4 883
FIGURE 1. Relationship between July 2006–December 2008 standardized mortality ratio (SMR) and January 2004–2006 SMR or hospital surgical vol-
ume. SMR ¼ observed number of deaths/expected number of deaths adjusted for surgery type. All R2 and P values are from Spearman correlation.
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DWhat, then, are the factors that may be contributing to an
improved prior mortality in those hospitals with a lower sur-
gical volume? There may be factors that hospitals that per-
form more higher-risk operations are more likely to
implement. For instance, such hospitals may be more likely
to have a dedicated cardiac intensive care unit, standardized
postoperative protocols, and 24-hour in-house attending
coverage. If these factors are important and low-volume
hospitals were also to institute these measures, this may ex-
plain why surgical volume fails to meet significance when
prior mortality is included in our models, particularly in
the lower-risk surgical categories. That is, smaller volume
hospitals may be able to attain mortality rates similar to
those of large volume hospitals by instituting important884 The Journal of Thoracic and Cardiovascular Surgquality improvement measures. Further research to eluci-
date these factors is certainly warranted.
Currently, hospital surgical volume is used as an impor-
tant criterion for referral for pediatric patients with congen-
ital heart disease to improve quality of care. This method of
referral has been shown to be associated with improvements
in mortality,18,19 and our findings agree with a prior study
that suggests that this referral model may be appropriate
for higher-risk cases.20 However, some have questioned
this approach and have proposed that past quality should
lead to higher volume, not the other way around.21,22 On
the basis of our findings, prior hospital mortality may be
an appropriate consideration in the referral process. Such
a system would reward those hospitals that focus onery c October 2011
TABLE 1. Factors associated with in-hospital mortality after surgery for congenital heart disease, July 2006–December 2008
Institution-level variables
Relative change in mortality per increase of
40 cases annually (95% CI)* P value
Surgical case volume, January 2004–June 2006 2.0% (4.1, 0.2) .0792
Relative change in mortality per 0.1 unit
decrease in SMR (95% CI)* P value
Standardized in-hospital mortality ratio
(SMR), January 2004–June 2006
3.4% (4.9,1.9) <.0001
Patient-level variables N (%) In-hospital mortality (%) Risk ratio (95% CI)* P value
Age
<30 d 5,878 (24.4) 9.0 Referent
30 d-1 y 8,700 (36.1) 1.9 0.31 (0.25, 0.38) <.0001
>1 y 9,534 (39.5) 0.9 0.15 (0.12, 0.19) <.0001
Race
White 17,391 (72.1) 2.9 Referent
Black 3,156 (13.1) 3.7 1.25 (1.03, 1.53) .0234
Other 3,565 (14.8) 4.3 1.39 (1.17, 1.64) .0002
Sex
Male 13,441 (55.7) 3.1 Referent
Female 10,671 (44.3) 3.4 1.18 (1.03, 1.36) .0158
Genetic syndrome
No 20,578 (85.3) 3.1 Referent
Yes 3,534 (14.7) 3.7 1.57 (1.30, 1.90) <.0001
Insurance type
Government 10,514 (43.6) 4.2 Referent
Private 8,605 (35.7) 2.5 0.71 (0.61, 0.84) <.0001
Other 4,993 (20.7) 2.3 0.73 (0.59, 0.89) .0022
RACHS-1 category
1 2,891 (12.0) 1.0 Referent
2 8,236 (34.1) 1.3 0.77 (0.51, 1.16) .2097
3 8,940 (37.1) 3.0 1.64 (1.11, 2.42) .0132
4 2,895 (12.0) 6.8 2.40 (1.60, 3.61) <.0001
5 or 6 1,150 (4.8) 15.2 3.67 (2.41, 5.58) <.0001
CI, Confidence interval; RACHS-1, Risk Adjustment for Congenital Heart Surgery; *Effect estimates are adjusted for all other variables in the table.
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Given the lack of widespread publicly available hospital
mortality data, however, this referral system would be
challenging to implement.23
Of course, creating a referral system based solely onmor-
tality as an outcome measure may not be the best method.
There are other important outcome measures that we did
not analyze, including but not limited to comorbidities
such as ventilation time or infections, cost measures such
as length of stay or resource utilization, and patient familyTABLE 2. Associations between January 2004-June 2006 hospital surgic
mortality by RACHS-1 categories
Case volume
RACHS-1 category
Relative change in mortality risk per
increase of 40 cases annually (95% CI)*
1, 2, 3 1.6% (5.2, 2.2)
4, 5, 6 14.4% (27.6, 1.2)
RACHS-1, Risk Adjustment for Congenital Heart Surgery; SMR, standardized in-hospital m
genetic syndrome, and insurance type.
The Journal of Thoracic and Cafactors such as satisfaction with care or perceived quality.
Consideration of outcomes in addition to mortality may
provide a better model for referral of care.24
Our study, which was based on data from a large admin-
istrative database, is not without its limitations. First, the
use of ICD-9 codes from administrative data has been
shown to be valid in identifying cases of congenital heart
disease, but it has also been shown to have some false-
positives.25,26 Inasmuch as our study included not only
diagnosis but also procedure code, we would expect thatal case volume and mortality and July 2006–December 2008 patient
SMR
P value
Relative change in mortality risk per 0.1
unit decrease in SMR (95% CI)* P value
.4122 2.8% (5.0,0.7) .0105
.0678 2.7% (4.4,1.0) .0015
ortality ratio; CI, confidence interval. *Effect estimates are adjusted for age, race, sex,
rdiovascular Surgery c Volume 142, Number 4 885
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Dthis false-positive rate would have been decreased. Second,
our data are limited to in-hospital mortality. The patient
who dies of potential surgical complications shortly after
discharge from the hospital would not be identified in our
data. Death from outpatient surgical complications may
be an important factor to consider when analyzing regional-
ization of operative care. Finally, although the use of data
from a large administrative database affords us greater
power in our study, comparing mortality rates between indi-
vidual hospitals may be difficult given limited case volume,
a spectrum of severity within RACHS-1 categories, varying
surgical approaches to similar lesions across institutions,
and improvements in mortality rates over time.27 In partic-
ular, in-hospital mortality is a relatively rare event, even for
hospitals with SMR above the median, and a difference of
just 1 or 2 deaths may have a marked impact on the SMR
estimates for low-volume hospitals.
CONCLUSIONS
In this data set, prior hospital surgical volume tended to
be associated with improved mortality after higher-risk op-
erations in pediatric patients having surgery for congenital
heart disease, whereas prior hospital postoperative mortal-
ity was significantly associated with mortality across all
risk strata of operations for congenital heart disease. Future
research is warranted to evaluate potential quality improve-
ment measures that would allow low-volume hospitals to
perform as well as or better than large-volume hospitals.
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